000 01002 a2200277 4500
005 20250517060905.0
264 0 _c20161101
008 201611s 0 0 eng d
022 _a1873-7560
024 7 _a10.1016/j.eururo.2015.10.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSonpavde, Guru
245 0 0 _aDocetaxel for Castration-sensitive Prostate Cancer: Wrapping up Unfinished Business?
_h[electronic resource]
260 _bEuropean urology
_cApr 2016
300 _a574-575 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOrchiectomy
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aProstatic Neoplasms, Castration-Resistant
_xdrug therapy
700 1 _aBellmunt, Joaquim
773 0 _tEuropean urology
_gvol. 69
_gno. 4
_gp. 574-575
856 4 0 _uhttps://doi.org/10.1016/j.eururo.2015.10.022
_zAvailable from publisher's website
999 _c25384008
_d25384008